Remove Banking Remove Clinical Trials Remove Patients Remove Treatment
article thumbnail

Real Money Publish A List Of Psychedelic Capitalist Roaders

Cannabis Law Report

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. After Approval, It’s Off to Treatment Clinics.

article thumbnail

India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors

Cannabis Law Report

He served on the Appropriation, Banking and Finance and Budget committees. He understands that treatment and education for conditions such as Autism and Alzheimer’s disease have the potential to positively impact millions of lives. He played a leadership role in the areas of defense, health, and the environment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Chemistree Investee ImmunoFlex™ Completes Clinical Study and Submits US and International Patent Applications

Cannabis Law Report

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. In one particular group, all patients showed consistent results across multiple genomic analyses.

article thumbnail

Cannabis and Cancer

Medical Cannabis Seedbank

Unfortunately, many of those victims are either unaware or simply have not been given the option of alternative treatments to the more orthodox chemotherapy. The alternative treatment that we will focus on in this post is the use of medical cannabis and its healing qualities. When patient. Countries such as the U.S.A

article thumbnail

MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

Our treatment designed for delaying aging has a distinctive drug profile of oral delivery, selectivity, and very low toxicity as compared with TNF blockers, all of which are delivered by injection only. “For The secondary measures will be the safety, tolerability, and pharmacokinetics in this population of patients.

article thumbnail

MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia

Cannabis Law Report

“This patent issuance is rewarding and timely as we launch our Phase 2 trial of MYMD-1 as a therapy for sarcopenia, frailty, and aging, which is currently recruiting patients,” said Chris Chapman, M.D., President, Director and Chief Medical Officer of MyMD.

article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. Preclinical studies involve exposing cells and animals to treatments to see if there are indications that the treatment could be worth evaluating in humans. What is the entourage effect?